• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the development of a new class of anticancer agents based on dimerization arm of the EGF receptor

Research Project

Project/Area Number 16K18910
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Drug development chemistry
Research InstitutionKitasato University (2017)
Tokyo Medical and Dental University (2016)

Principal Investigator

MIZUGUCHI Takaaki  北里大学, 薬学部, 助教 (30732557)

Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsEGFレセプター / 二量体化アーム / 環状ぺプチド / 細胞内送達分子 / 抗がん活性ペプチド / EGF受容体 / 二量体化阻害 / 環状ペプチド / 細胞内送達 / 細胞内薬物送達分子 / ドラッグデリバリー / 蛍光イメージング / フローサイトメトリー / 抗がん剤 / 中分子 / 薬学 / 創薬化学 / ケミカルバイオロジー / ペプチド / 有機化学
Outline of Final Research Achievements

In many cancer cells, unregulated activation of epidermal growth factor (EGF) receptor often causes the aberrant cell growth. For this reason, this receptor is a useful medicinal target for the development of anticancer drugs. In this study, the results of structure-activity relationship studies of our inhibitory cyclic peptide 1 against the EGF receptor dimerization indicated that the tyrosine and threonine side-chains on the N- and C-terminal side of peptide 1, respectively, would be essential for the inhibitory effect on the EGF receptor dimerization. Besides, the addition of a polar amino acid or weakly charged histidine to the N-terminal of peptide 1 improved the inhibitory effect on the EGF receptor dimerization.
In addition, fluorescein-labeled peptide 1 at the N-terminus and the derivative would be taken up by cells expressing high levels of EGF receptor, according to the experimental results with genetic engineering procedure.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • Research Products

    (4 results)

All 2017 2016 Other

All Journal Article (1 results) (of which Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results) (of which Int'l Joint Research: 2 results) Remarks (1 results)

  • [Journal Article] Effects of replacement and addition of an amino acid contained in a cyclic peptide corresponding to a β-hairpin loop sequence of human EGF receptor2017

    • Author(s)
      Kobayashi K, Mizuguchi T, Hattori Y, Ohara N, Ninomiya R, Iida M, Ooe H, Yamazaki Y, Takata M, Tamamura H, Akaji K
    • Journal Title

      Journal of Peptide Science

      Volume: 印刷中 Issue: 7-8 Pages: 581-586

    • DOI

      10.1002/psc.3004

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Functional Evaluation of Fluorescein-Labeled Peptides Based on the EGF Receptor Dimerization Arm Sequences2016

    • Author(s)
      Toyama K, Mizuguchi T, Nomura W, Tamamura H.
    • Organizer
      34th European Peptide Symposium 2016 & 8th International Peptide Symposium
    • Place of Presentation
      Leipzig, Germany
    • Year and Date
      2016-09-08
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Presentation] Development of New Fluorescein-Labeled Peptides with Inhibitory Effect on the EGF Receptor Activation2016

    • Author(s)
      Toyama K, Mizuguchi T, Nomura W, Tamamura H.
    • Organizer
      The 20th Korean Peptide Protein Society Symposium.
    • Place of Presentation
      Yangyang, Korea
    • Year and Date
      2016-06-24
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Remarks] 東京医科歯科大学・生体材料工学研究所・メディシナルケミストリー分野・研究業績

    • URL

      http://tamamura-tmd.sakura.ne.jp/kenkyu/gyoseki/

    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi